Supreme Court rejects Monsanto’s request to stop Roundup lawsuits

New setback for Bayer. Tuesday, June 21, the Supreme Court of the United States refused the appeal request of Monsanto, owned by the German group since 2018, definitively determining its sentence to pay 25 million dollars (more than 23 million euros) to a retiree who blamed his cancer on the weed killer Roundup.

In accordance with custom, the high court did not justify its decision, which risks having serious consequences for the group, targeted by more than 30,000 comparable complaints.

“Bayer respectfully disagrees with the Supreme Court decision [mais] is fully prepared to face the legal risk associated with potential future claims in the United States”, reacted the group in a press release. Bayer Group said it has set aside an additional $4.5 billion to deal with new procedures. The company specifies “Admits no wrong or liability” and “continue to support its Roundup products, a valuable tool for efficient agricultural production around the world”.

Read also Article reserved for our subscribers Roundup: Bayer to pay $10 billion to stop lawsuits but admits no wrongdoing

The Court’s choice not to intervene leaves in place Monsanto’s conviction on appeal in the lawsuit brought by Edwin Hardeman, who was determined to have non-Hodgkin’s lymphoma in 2015. Mr. Hardeman was one of the first suspects to attack Monsanto in court, blaming his cancer on the herbicide he had used on his large property for twenty-five years and accusing the Monsanto group of misleading users by claiming that the glyphosate product was harmless.

Read also Article reserved for our subscribers Glyphosate can disrupt microbiota at very low doses, international study finds

Denigration and intimidation

Monsanto has thus always insisted that no study had concluded that glyphosate and Roundup, which were marketed in the 1970s, were dangerous. In March 2015, the International Agency for Research on Cancer (IARC), the agency of the World Health Organization responsible for listing carcinogens, had, however, classified glyphosate as “probable carcinogen” for the man.

The disclosure, in 2018, in the context of the lawsuits against Monsanto, of numerous internal documents of the American company – the “Monsanto Papers” – also highlighted its numerous maneuvers to influence public expertise on glyphosate, denigrate the CIRC, intimidate certain scientists or even receive scientific studies without appearing in its signatories.

Read also Article reserved for our subscribers Glyphosate, expertise and mistrust

The World with AFP

Leave a Comment